This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by di Pietro, M. Articles by Jiricny, J. Search for Related Content PubMed PubMed Citation Articles by di Pietro, M. Articles by Jiricny, J.

Mismatch Repair-Dependent Transcriptome Changes In Human Cells Treated with the Methylating Agent N-Methyl-N'-Nitro-N-Nitrosoguanidine

¹ Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland, and
² Department of Public Health, University "La Sapienza," Rome, Italy

DNA mismatch repair (MMR) plays a key role in the cytotoxic response of human cells to methylating agents, however, the cascade of events leading to cell cycle arrest and cell death has yet to be characterized. We studied the role of MMR in the transcriptional response to DNA methylation damage in two human cellular models: (a) the lymphoblastoid cell line TK6 and its derivative MT1, which is mutated in the MMR gene hMSH6; and (b) the epithelial cell line 293T L in which the expression of the MMR gene hMLH1 can be tightly regulated and p53 is inactivated. Upon N-methyl-N'-nitro-N-nitrosoguanidine treatment, only cells with functional MMR were killed, but the type of cytotoxic response differed. In TK6 cells, S-phase arrest and apoptosis were accompanied by a dramatic change in gene expression, notably, an up-regulation of several genes encoding growth inhibitors and proapoptotic factors both p53 dependent and independent. In contrast, the MMR-dependent transcriptional response in 293T L cells was substantially less pronounced than in TK6 cells, despite an efficient induction of a G₂-M checkpoint and nonapoptotic cell death. Thus, we demonstrate that in human cells of different origin, MMR-mediated killing by methylating agents occurs through different pathways and regardless of the p53 status. Moreover, once DNA methylation damage has been processed by the MMR system, tumor cells might be committed to die, although one or more of their signaling pathways are impaired.

This article has been cited by other articles:

				J. Sabates-Bellver, L. G. Van der Flier, M. de Palo, E. Cattaneo, C. Maake, H. Rehrauer, E. Laczko, M. A. Kurowski, J. M. Bujnicki, M. Menigatti, et al. Transcriptome Profile of Human Colorectal Adenomas Mol. Cancer Res., December 1, 2007; 5(12): 1263 - 1275. [Abstract] [Full Text] [PDF]

				E. Cannavo, G. Marra, J. Sabates-Bellver, M. Menigatti, S. M. Lipkin, F. Fischer, P. Cejka, and J. Jiricny Expression of the MutL Homologue hMLH3 in Human Cells and its Role in DNA Mismatch Repair Cancer Res., December 1, 2005; 65(23): 10759 - 10766. [Abstract] [Full Text] [PDF]

				L. Stojic, N. Mojas, P. Cejka, M. di Pietro, S. Ferrari, G. Marra, and J. Jiricny Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase Genes & Dev., June 1, 2004; 18(11): 1331 - 1344. [Abstract] [Full Text] [PDF]

				E. Papouli, P. Cejka, and J. Jiricny Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells Cancer Res., May 15, 2004; 64(10): 3391 - 3394. [Abstract] [Full Text] [PDF]